STERIS plc (NYSE:STE) Shares Acquired by Southeast Asset Advisors LLC

Southeast Asset Advisors LLC increased its stake in STERIS plc (NYSE:STE) by 131.2% during the 4th quarter, Holdings Channel reports. The fund owned 17,961 shares of the medical equipment provider’s stock after purchasing an additional 10,191 shares during the quarter. Southeast Asset Advisors LLC’s holdings in STERIS were worth $3,692,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avalon Trust Co acquired a new stake in shares of STERIS in the 4th quarter valued at $30,000. Human Investing LLC acquired a new stake in STERIS in the fourth quarter valued at $31,000. Anfield Capital Management LLC lifted its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division boosted its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 137 shares during the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

STERIS Trading Down 3.7 %

Shares of STE stock opened at $213.16 on Monday. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The business’s fifty day moving average price is $223.23 and its 200 day moving average price is $220.44. The firm has a market capitalization of $20.94 billion, a PE ratio of 45.26 and a beta of 0.87.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.07%. STERIS’s dividend payout ratio is presently 48.41%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.